Table 1.
Dosage form/strength | Primary mechanism of action | Comedonal | Inflammatory | |
---|---|---|---|---|
Monotherapy | ||||
Adapalene |
Cream, gel or lotion: 0.1% Gel: 0.3% |
Anti-inflammatory, keratolytic | X | X |
Tazarotene |
Cream or gel: 0.05%, 0.1% Foam: 0.1% |
Anti-inflammatory, keratolytic | X | X |
Tretinoin |
Cream: 0.02%, 0.025%, 0.0375%, 0.05%, 0.075%, 0.1% Gel: 0.01%, 0.025%, 0.04%, 0.05%, 0.1% Microsphere gel: 0.04%, 0.08%, 0.1% |
Anti-inflammatory, keratolytic | X | X |
Benzoyl peroxide | Gel, cream, lotion, pads or wash: 2.5–10% | Antimicrobial | X | X |
Azelaic acid |
Cream: 20% Foam or gel: 15% |
Antimicrobial, anti-inflammatory, keratolytic | X | X |
Primary mechanism of action | Comedonal | Inflammatory | ||
---|---|---|---|---|
Combination treatment | ||||
Clindamycin/benzoyl peroxide | Antimicrobial | X | X | |
Clindamycin/tretinoin | Antimicrobial, anti-inflammatory, keratolytic | X | X | |
Clindamycin/adapalene | Antimicrobial, anti-inflammatory, keratolytic | X | X | |
Clindamycin/salicylic acid | Antimicrobial, anti-inflammatory, desquamation | X | X | |
Dapsone/adapalene | Antimicrobial, anti-inflammatory, keratolytic | X | X | |
Dapsone/benzoyl peroxide | Antimicrobial, anti-inflammatory | X | X | |
Erythromycin/zinc acetate | Antimicrobial | X | ||
Erythromycin/benzoyl peroxide | Antimicrobial | X | X | |
Erythromycin/tretinoin | Antimicrobial, anti-inflammatory, keratolytic | X | X | |
Adapalene/benzoyl peroxide | Antimicrobial, anti-inflammatory, keratolytic | X | X | |
Zinc pyrrolidone/seaweed-derived oligosaccharide | Antimicrobial, anti-inflammatory | X | X |